Levin Capital Strategies, L.P. Alpha Tau Medical Ltd. Transaction History
Levin Capital Strategies, L.P.
- $996 Million
- Q1 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 338,764 shares of DRTS stock, worth $857,072. This represents 0.1% of its overall portfolio holdings.
Number of Shares
338,764
Previous 330,123
2.62%
Holding current value
$857,072
Previous $993,000
0.6%
% of portfolio
0.1%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding DRTS
# of Institutions
30Shares Held
1.92MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY309KShares$780,7120.0% of portfolio
-
Hoyle Cohen, LLC269KShares$680,7920.06% of portfolio
-
Corbin Capital Partners, L.P. New York, NY260KShares$658,0751.86% of portfolio
-
High Tower Advisors, LLC Chicago, IL213KShares$537,6450.0% of portfolio
-
Atalaya Capital Management LP New York, NY73.7KShares$186,5670.57% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $175M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...